These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17690574)

  • 1. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine.
    Kuhn L; Schramm DB; Donninger S; Meddows-Taylor S; Coovadia AH; Sherman GG; Gray GE; Tiemessen CT
    AIDS; 2007 Aug; 21(13):1753-61. PubMed ID: 17690574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced ability of newborns to produce CCL3 is associated with increased susceptibility to perinatal human immunodeficiency virus 1 transmission.
    Meddows-Taylor S; Donninger SL; Paximadis M; Schramm DB; Anthony FS; Gray GE; Kuhn L; Tiemessen CT
    J Gen Virol; 2006 Jul; 87(Pt 7):2055-2065. PubMed ID: 16760409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3L1 and CCL4L1: variable gene copy number in adolescents with and without human immunodeficiency virus type 1 (HIV-1) infection.
    Shao W; Tang J; Song W; Wang C; Li Y; Wilson CM; Kaslow RA
    Genes Immun; 2007 Apr; 8(3):224-31. PubMed ID: 17330138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
    Jackson JB; Parsons T; Musoke P; Nakabiito C; Donnell D; Fleming T; Mirochnick M; Mofenson L; Fowler MG; Mmiro F; Guay L
    AIDS; 2006 Jan; 20(2):217-22. PubMed ID: 16511414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries.
    Stringer EM; Ekouevi DK; Coetzee D; Tih PM; Creek TL; Stinson K; Giganti MJ; Welty TK; Chintu N; Chi BH; Wilfert CM; Shaffer N; Dabis F; Stringer JS;
    JAMA; 2010 Jul; 304(3):293-302. PubMed ID: 20639563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of intragenic CCL3 haplotypes and CCL3L copy number in HIV-1 infection in a sub-Saharan African population.
    Paximadis M; Schramm DB; Gray GE; Sherman G; Coovadia A; Kuhn L; Tiemessen CT
    Genes Immun; 2013 Jan; 14(1):42-51. PubMed ID: 23151487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P; Spitzer RF; Glazier RH; Pilon R; Arbess G; Simor A; Boyle E; Chitsike I; Chipato T; Gottesman M; Silverman M
    Clin Infect Dis; 2007 Jan; 44(1):111-9. PubMed ID: 17143826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
    Musoke P; Guay LA; Bagenda D; Mirochnick M; Nakabiito C; Fleming T; Elliott T; Horton S; Dransfield K; Pav JW; Murarka A; Allen M; Fowler MG; Mofenson L; Hom D; Mmiro F; Jackson JB
    AIDS; 1999 Mar; 13(4):479-86. PubMed ID: 10197376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
    Baroncelli S; Galluzzo CM; Mancinelli S; Andreotti M; Jere H; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
    Infect Dis (Lond); 2016 Apr; 48(4):317-321. PubMed ID: 26609569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose Nevirapine during pregnancy.
    Sax PE
    AIDS Clin Care; 1999 Oct; 11(10):84-5. PubMed ID: 11366708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of perinatal HIV infection: cause for optimism.
    Lindsay MK
    AIDS Clin Care; 1999 Dec; 11(12):95-7, 99, 102. PubMed ID: 11366712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-cost drug cuts perinatal HIV-transmission rate.
    McCarthy M
    Lancet; 1999 Jul; 354(9175):309. PubMed ID: 10440319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.
    Desmond AC; Moodley D; Conolly CA; Castel SA; Coovadia HM
    BMC Pediatr; 2015 Mar; 15():23. PubMed ID: 25885678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal HIV prevention.
    Stephenson J
    JAMA; 1999 Aug; 282(7):625. PubMed ID: 10532854
    [No Abstract]   [Full Text] [Related]  

  • 19. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.
    Chi BH; Sinkala M; Mbewe F; Cantrell RA; Kruse G; Chintu N; Aldrovandi GM; Stringer EM; Kankasa C; Safrit JT; Stringer JS
    Lancet; 2007 Nov; 370(9600):1698-705. PubMed ID: 17997151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in Sub-Saharan Africa, 2004-2005.
    Boeke CE; Jackson JB
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(3):133-40. PubMed ID: 18460695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.